The store will not work correctly when cookies are disabled.
2-[(E)-1-Methyl-2-(5-nitro-thiophen-2-yl)-vinyl]-1H-benzoimidazole
ID: ALA117536
PubChem CID: 11185239
Max Phase: Preclinical
Molecular Formula: C14H11N3O2S
Molecular Weight: 285.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C/C(=C\c1ccc([N+](=O)[O-])s1)c1nc2ccccc2[nH]1
Standard InChI: InChI=1S/C14H11N3O2S/c1-9(8-10-6-7-13(20-10)17(18)19)14-15-11-4-2-3-5-12(11)16-14/h2-8H,1H3,(H,15,16)/b9-8+
Standard InChI Key: MLDRKPBYJLUXKJ-CMDGGOBGSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
0.6875 -1.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0167 -2.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -0.7917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6875 -3.0667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2042 -2.1250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2292 -2.8292 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.5167 -1.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7500 -2.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9250 -2.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0167 -1.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5833 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5833 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2292 -1.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6000 -3.8875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4417 -2.7292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9250 -0.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2958 -0.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2958 -2.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -1.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 6 1 0
3 1 2 0
4 2 1 0
5 1 1 0
6 8 1 0
7 1 1 0
8 9 1 0
9 7 2 0
10 13 1 0
11 3 1 0
12 5 1 0
13 8 2 0
14 4 1 0
15 4 2 0
16 7 1 0
17 11 1 0
18 12 1 0
19 18 2 0
20 17 2 0
12 11 2 0
20 19 1 0
2 10 2 0
M CHG 2 4 1 14 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 285.33 | Molecular Weight (Monoisotopic): 285.0572 | AlogP: 4.09 | #Rotatable Bonds: 3 |
Polar Surface Area: 71.82 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.49 | CX Basic pKa: 5.20 | CX LogP: 4.30 | CX LogD: 4.29 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.58 | Np Likeness Score: -1.65 |
References
1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ.. (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles., 47 (13): [PMID:15189040] [10.1021/jm0311036] |